Apollo Health Ventures
Investor profile
Venture capital
Deals
4
distinct rounds
Companies
4
backed
Active span
2022–2025
4 yrs
Total round €
€79M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- +ND Capital1
- 4see Ventures1
- AlbionVC1
- Alexandria Venture Investments1
- Athos Capital1
- Bernina BioInvest1
- Boehringer Ingelheim Venture Fund (BIVF)1
- Curie Capital B.V.1
- Earlybird Venture Capital1
- Eli lilly and company1
- High-Tech Gründerfonds (HTGF)1
- LifeLink Ventures1
- Longevitytech.fund1
- Longview Ventures1
- NRW.Venture1
- Oxford Science Enterprises (OSE)1
- Oxford University Innovation Fund1
- Parkwalk Advisors1
- ROM Utrecht Region1
- Schroders Capital1
- Sofinnova Partners1
- YZR Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| haya therapeutics | Switzerland | 1 | €57M |
| Scripta Therapeutics | UK | 1 | €10M |
| Refoxy Pharmaceuticals | Germany | 1 | €9.1M |
| Cleara Biotech B.V. | Netherlands | 1 | €2.6M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| haya therapeutics | Series A | €57M | 2025-05 |
| Scripta Therapeutics | Seed | €10M | 2025-11 |
| Refoxy Pharmaceuticals | Seed | €9.1M | 2024-12 |
| Cleara Biotech B.V. | Seed | €2.6M | 2022-09 |